Front Matter

Faculty

Lorraine M. Provencher, MD

• Cataract, Anterior Segment, and Glaucoma Surgeon
• Vance Thompson Vision
• Omaha, Nebraska

Emily M. Schehlein, MD

• Cataract & Glaucoma Surgeon
• Brighton Vision Center
• Brighton, Michigan

Manjool Shah, MD

• Associate Professor and Program Director of Glaucoma Fellowship
• NYU Langone Health Department of Ophthalmology
• Physician, NYU Langone Health and Bellevue Hospital
• New York, New York

Inder Paul Singh, MD

• President and Ophthalmologist
• The Eye Centers of Racine and Kenosha
• Racine and Kenosha, Wisconsin

Swarup S. Swaminathan, MD

• Associate Professor of Clinical Ophthalmology
• Bascom Plamer Eye Institute
• University of Miami
• Miami, Florida
• Associate Professor of Public Health Sciences
• University of Miami
• Coral Gables, Florida

Zarmeena Vendal, MD

• Cataract & Glaucoma Surgeon
• Founder, Westlake Eye Specialists
• Austin, Texas

Activity Description

This supplement provides an in-depth summary of an expert panel discussion on the management of early-stage glaucoma. It focuses on achieving consensus among specialists on the incidence, risk factors, diagnosis, decision-making and treatment processes, and patient communication strategies to enhance the care of patients with early-stage glaucoma.

Target Audience

This CME activity is designed for ophthalmologists.

Learning Objectives

A. Define and assess the incidence, risk factors, and diagnostic tools for early detection of glaucoma. (Knowledge)
B. Compare and integrate treatment options and decision-making processes for glaucoma management. (Competence, Performance)
C. Evaluate and implement patient communication strategies and non-preset scans for enhanced care. (Competence, Performance)

Grant Support Statement

This activity is supported by unrestricted educational grants from AbbVie, Alcon, and Glaukos, and the content is supplied by The Fundingsland Group.

Accreditation Statement

The Fundingsland Group, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Fundingsland Group, LLC, designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Once you’re logged into the course, you must complete the pre-test, view the activity, successfully pass the post-test, and complete the evaluation.

Only candidates with a passing score of at least 70% earn credit. Candidates have the opportunity to retake the post-test until a passing score is achieved. The course credit certificate will appear in the Certificates section of your account automatically upon successful completion of the course.

For any additional questions about obtaining credit, please email info@tfgeducation.com.

Disclosure Policy

It is the policy of The Fundingsland Group (TFG) that faculty and other individuals in a position to control content of this activity disclose all financial relationships with ACCME defined ineligible companies within the past 24 months. TFG has policies in place that have identified relevant relationships and mitigated any real or apparent conflicts of interest prior to this educational activity.

Faculty Disclosures

Lorraine M. Provencher, MD, Faculty Member, has the following relevant financial relationships: Consultant: Elios Vision and Thea. Consultant & Speaker: AbbVie, Alcon, and Glaukos. Speaker: RxSight. Research: BVI, Bausch + Lomb, and Carl Zeiss Meditec. Stockholder (publicly traded company): New World Medical. Stockholder (publicly traded company), Speaker, & Research: MicroSurgical Technology. Stock Options: Radius.

Emily M. Schehlein, MD, Faculty Member, has the following relevant financial relationships: Consultant: AbbVie, Elios Vision, Glaukos, and MicroSurgical Technology. Consultant and Speaker: Alcon.

Manjool Shah, MD, Faculty Member, has the following relevant financial relationships: Consultant: AbbVie, Alcon, Bausch + Lomb, Corza, Glaukos, MST, New World Medical, Sight Sciences. Speaker: AbbVie, Alcon, Glaukos, MST.

Inder Paul Singh, MD, Faculty Member, has the following relevant financial relationships: Consultant: BVI. Consultant, Speaker and Research: AbbVie, Alcon, Bausch+Lomb, Glaukos, Lumibird, New World Medical, Rayner, and Zeiss. Research: Sight Sciences.

Swarup S. Swaminathan, MD, Faculty Member, has the following relevant financial relationships: Consultant: AbbVie. Board/Committee Member and Consultant: Lumata Health. Other (Financial Support received): Elios Vision – Relationship has ended.

Zarmeena Vendal, MD, Faculty Member, has the following relevant financial relationships: Board/Committee Member and Consultant: Vialase. Board/Committee Member, Consultant, Research: Sight Sciences. Consultant: AbbVie, Alcon, Bausch + Lomb, Glaukos, and Ocular Therapeutix. Consultant and Research: Biotissue, Johnson & Johnson, and RxSight.

Laura Straub, Staff, has the following relevant financial relationships: Consultant: LaunchLab Partners, Powers and Company, MJM, and Holliday Communications. The following financial relationships as a consultant have ended: Avisi Technologies, Nova Eye, Rayner, RxSight, STAAR Surgical, and Zeiss.

All other Fundingsland Group staff, planners, reviewers, and writers have no financial relationships with ineligible companies.

All identified relevant financial relationships have been mitigated and the educational content thoroughly evaluated for fair, balanced, and safe, effective patient care.

Off-label Statement

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The objective of TFG in developing continuing medical education activities is to promote the free expression and interchange of ideas and information for educational purposes. TFG does not accept responsibility for any opinions, positions, or statements contained or expressed in such material, and such opinions, positions and statements are not necessarily those of the TFG. Courses are intended to provide instruction leading to new knowledge and/or skills. TFG does not certify competence upon completion of the courses. The information presented is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.